Statistics for ArTara Therapeutics (id:6973 TARA)
Valuation metrics
Market cap
53.22M
Enterprise value
-31,372,188.00
Trailing P/E (ttm)
-0.67
Forward P/E
-0.81
PEG ratio
-0.81
Price/Sales (ttm)
Price/Book (mrq)
0.58
Enterprise Value/Revenue
Enterprise Value/EBITDA
0.72
Overview
Shares outstanding
20.63M
Float
15.17M
Shares short
2.32M
% Held by insiders
0.06%
% Held by institutions
0.51%
Average volume (10 days)
156.38K
Average volume (90 days)
Price summary
52-Week low
1.20
52-Week high
5.24
52-Week change
44.35%
Beta
1.79
50-Day moving average
1.99
200-Day moving average
2.68
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
January 10th, 2020
Ex-dividend date
Last split factor
2:1
Last split date
January 10th, 2020
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-28.11%
Return on equity
-45.90%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-43,901,000.00
Net income to common (ttm)
-40,689,000.00
Diluted EPS (ttm)
-3.03
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
89.58M
Total cash per share (mrq)
4.34
Total debt (mrq)
4.98M
Total Debt/Equity (mrq)
5.41
Current ratio (mrq)
1.63K%
Book value per share (mrq)
4.46
Cash flow
Cash flow statement
-33,327,000.00
Levered free cash flow (LFCF)
-20,307,124.00